Meyka Pro banner
Becton, Dickinson and Company

Becton, Dickinson and Company (BDX) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

BDX●NYSE
HealthcareMedical - Instruments & Supplies
$212.78
$0.10(0.05%)
U.S. Market opens in 51h 34m

Becton, Dickinson and Company (BDX)

Meyka AI Score

Z

Key Financials

Market Cap57.9B
P/E Ratio51.50
EPS (TTM)$13.00
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$220.24
3 Months$198.33
1 Year Target$169.90

BDX Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Becton, Dickinson and Company (NYSE: BDX) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Becton, Dickinson and Company's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BDX on the NYSE shows an RSI of 62.76, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $169.90 for the NYSE listing.

Key metrics behind Becton, Dickinson and Company's NYSE-traded stock include a P/E ratio of 51.50 and a market capitalization of 57.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BDX on the NYSE.

Price Performance (NYSE: BDX)

1-Day Change
0.05%
5-Day Change
-2.05%
1-Month Change
9.79%
3-Month Change
13.41%
6-Month Change
44.80%
Year-to-Date (YTD) Change
39.46%
1-Year Change
42.77%
3-Year Change
15.83%
5-Year Change
13.10%
All-Time (Max) Change
820.33%

Contact Information

201 847 6800
1 Becton Drive, Franklin Lakes, NJ, 07417-1880

Company Facts

600,000 Employees
IPO DateFeb 21, 1973
CountryUS
Actively Trading

Frequently Asked Questions